Medicare Frequently Asked Questions (FAQs)
Resource updated 05/16/2024
Resource updated 05/16/2024
Resource updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource updated 06/13/2023
Resource updated 10/09/2023
Resource updated 06/13/2023
Barriers and facilitators to HCV treatment during the DAA era for the understudied and high-risk population of HIV/HCV co-infected patients who delay or do not consent to treatment, and interventions for increasing DAA treatment uptake.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 05/15/2024
Resource updated 03/11/2024
Resource from the RWHAP Best Practices Compilation updated on 05/20/2024
Resource updated 10/16/2023
Resource updated 03/11/2024
Resource updated 10/04/2023
Resource updated 05/10/2023
Resource updated 03/18/2024
Resource updated 05/15/2024
Resource updated 07/17/2024
Resource from the RWHAP Best Practices Compilation updated on 01/17/2024
Resource updated 10/23/2023
Resource updated 07/10/2024